NXPH4 and hepatocellular carcinoma: The findings demonstrated that increased NXPH4 expression was strongly associated with adverse survival in HCC, including overall survival (OS, Figure 4(a), p = 0.00052), recurrence free survival (RFS, Figure 4(b), p = 0.044), progression free survival (PFS, Figure 4(c), p = 0.0099), and disease specific survival (DSS, Figure 4(d), p = 0.0032).